Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural mesothelioma

C Boutin1, M Schlesser, C Frenay

  • 1Dept of Pulmonary Diseases, Hôpital de La Conception, Marseille, France.

The European Respiratory Journal
|November 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Very long-term survival of a bronchial adenoid cystic-carcinoma treated bronchoscopically.

Respiratory medicine and research·2022
Same author

A novel pleural-bladder pump for the management of recurrent malignant pleural effusions: a feasibility animal study.

Respiratory research·2020
Same author

Statistical analysis of the effluent quality of 231 on-site sanitation facilities in France monitored during a 6-year period.

Water science and technology : a journal of the International Association on Water Pollution Research·2019
Same author

[Management of a tracheal adenoid cystic medico-surgical carcinoma].

Revue des maladies respiratoires·2018
Same author

[Trans-vocal cord prostheses - preliminary experience treating benign laryngotracheal stenosis in adults].

Revue des maladies respiratoires·2018
Same author

Macrophytes are highly sensitive to the herbicide diquat dibromide in test systems of varying complexity.

Ecotoxicology and environmental safety·2018

Malignant pleural mesothelioma (MPM) has a poor prognosis, but early diagnosis and multimodal therapy may improve outcomes. Further research is needed to establish optimal treatment strategies for MPM.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pulmonology

Background:

  • Malignant pleural mesothelioma (MPM) incidence has increased, with a poor prognosis and limited effective treatments.
  • Current survival rates are approximately 12-17 months post-diagnosis.
  • Early screening for MPM has received limited attention due to its generally poor prognosis.

Purpose of the Study:

  • To review current understanding of malignant pleural mesothelioma diagnosis and treatment.
  • To discuss potential benefits of early diagnosis and multimodal therapy.
  • To outline proposed treatment strategies based on disease stage.

Main Methods:

  • Histological analysis of thoracoscopy samples for diagnosis and staging.
  • Assessment of visceral pleural involvement as a prognostic factor.

Related Experiment Videos

  • Review of existing treatment modalities including radiotherapy, surgery, chemotherapy, and immunotherapy.

    • Main Results:

    • Thoracoscopy is crucial for accurate staging and identifying prognostic factors.
    • No single treatment has demonstrated definitive superiority in randomized trials.
    • Early-stage MPM may benefit from neoadjuvant intrapleural cytokine therapy.
    • Advanced stages may require multimodal treatment including surgery, radiotherapy, and chemotherapy.

    Conclusions:

    • Early diagnosis and multimodal therapy, including intrapleural immunotherapy, may offer improved prognosis for certain MPM cases.
    • Treatment strategies should be tailored to disease stage, with consideration for neoadjuvant therapy in early stages and multimodal approaches in advanced stages.
    • Enrollment in clinical trials is recommended for all MPM patients to advance treatment research.